Malar augmentation with Hyaluronic acid enriched with glycine and proline: a clinical evaluation

A Scarano, D Amuso, R Amore, A Greco Lucchina, F Inchingolo, M Marchetti, F Lorusso

Article ID: 5464
Vol 35, Issue 2S1, 2021
DOI: https://doi.org/10.23812/21-2supp1-19
Received: 9 May 2021; Accepted: 9 May 2021; Available online: 9 May 2021; Issue release: 9 May 2021

Abstract

The aging process causes skin modification and wrinkle formation with an alteration of the face harmony and imperfections. The aim of the present investigation was to evaluate a cross-linked hyaluronic acid enriched with glycine and proline for zygomatic malar region infiltrations. A total of twenty healthy female patients were treated for zygomatic hypotonia. The level of patients and surgeon satisfaction was evaluated by global aesthetic improvement scale (GAIS) at baseline, immediately after the procedure and at 6 months from the treatment. The healing phase was uneventful, and no complications were reported in the perioperative and follow-up periods. No significant differences were reported between patients and surgeon GAIS score (p<0.05). A significant difference of GAIS score was reported immediately after the procedure and at 6 months if compared to the baseline (p<0.05). The cross-linked hyaluronic acid enriched with glycine and proline is a useful biomaterial for zygomatic- malar augmentation with no significant local complications and a high stability and satisfaction level of the procedure.


Keywords

glycine and proline;hyaluronic acid;skin rejuvenation;soft tissues augmentation;zygomatic malar augmentation


References

Supporting Agencies



Copyright (c) 2021 A Scarano, D Amuso, R Amore, A Greco Lucchina, F Inchingolo, M Marchetti, F Lorusso




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).